Levron Cardiovascular
Minimally Invasive Device for Heart Failure
StartupLevron Cardiovascular is a Yokne'am Illit-based startup in the Health Tech & Life Sciences sector, established in 2021. Minimally Invasive Device for Heart Failure. Levron Cardiovascular was founded by Meir Kenigsztein, Dr. Shimon Eckhouse, Prof. Amir Landesberg. Key investors include Shoni Health Ventures, Alon MedTech Ventures. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
The company follows a B2C business model. Product stage: Clinical Trial.
- StageSeed
- ProductClinical Trial
- ModelB2C
- Employees1-10
- HQYokne'am Illit
- Last RoundUndisclosed
- Shoni Health Ventures
- Alon MedTech Ventures
Meir KenigszteinCo-founder & former CEO
Dr. Shimon EckhouseCo-founder
Prof. Amir LandesbergCo-founder & CSO
What does Levron Cardiovascular do?
Levron is developing a novel autonomic integrated diagnostic and therapeutic minimally invasive device intended to be used with cardiac failure patients. The company's device integrates diagnosis and treatment, shifts fluids from the lung, and reduces cardiac workloads. The device provides adaptive treatment for NYHA stage 3 heart failure, eliminating lung congestion.
Who founded Levron Cardiovascular?
Levron Cardiovascular was founded in 2021 by Meir Kenigsztein (Co-founder & former CEO), Dr. Shimon Eckhouse (Co-founder), Prof. Amir Landesberg (Co-founder & CSO).
What sector is Levron Cardiovascular in?
Levron Cardiovascular operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Medical Equipment, Healthcare, Patients.
Where is Levron Cardiovascular located?
Levron Cardiovascular is based in HaKidma St 28, Yokne'am Illit, 20692, Israel.